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Resorcinols have been much used as depigmenting agents in dermatology (Shimizu et al., 
2000; Solano et al., 2006; Chang, 2009) but their mode of action has until recently been obscure. A 
series of studies of suicide inactivation of tyrosinase (Land et al., 2007; Land et al., 2008; Ramsden et 
al., 2009; Ramsden and Riley, 2010a; Ramsden and Riley, 2010b) demonstrated that the process 
requires monooxygenase (cresolase) activity and indicated the manner by which resorcinols act as 
inactivators of tyrosinase by altering the oxidation state of an active site copper atom (Ramsden and 
Riley, 2014a). A study of this process employing a series of substituted resorcinols gave results 
consistent with the proposed inactivation mechanism (Stratford et al., 2013). However, an unexpected 
exception was found in the case of 5-hydroxyresorcinol (5-HR) which, in contrast to other 5-
substituted resorcinols, not only failed to exhibit an inactivating effect but, on the contrary, appeared 
to be an activator of tyrosinase.  We report here the results of our investigations of this strikingly 
anomalous behaviour.  
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In brief, we have shown that 5-HR (1) is not a substrate for tyrosinase, showing no oxygen 
utilisation, no alteration in spectral absorbance, no evidence of any product detectable by HPLC/MS, 
and no evidence of any diminution in tyrosinase activity on subsequent testing with known substrates 
such as 4-ethylphenol (EtP, 2) and 4-methoxyphenol (MOP). We have excluded the failure to act 
as a primary substrate due to a mechanism similar to that for hydroquinone, which involves a 
1,2-benzoquinone to 1,4-benzoquinone tautomerism (Ramsden and Riley, 2014b). We have 
also demonstrated that 5-hydroxyresorcinol is not a secondary tyrosinase substrate since no 
oxidation of 5-hydroxyresorcinol takes place after tyrosinase activation by prior oxidation of 
4-ethylphenol. 
Experiments in which 5-HR-treated tyrosinase was exposed to EtP (2) showed the generation 
of a product absorbing at 450 nm not observed in the absence of 5-HR, associated with increased 
oxidation rate, diminished lag period and increased total oxygen utilisation. Similar results were 
obtained with MOP (see Table 1) implying that the enzyme is activated by a catechol. Since the 
formation of a catechol cannot be by a direct redox reaction with 5-HR, we propose that the 450 nm 
absorbing product is a compound derived from a 1,2-benzoquinone and 5-HR. We were able to 
confirm by pulse radiolysis using 4-ethylcatechol and 4-methoxycatechol that the 450 nm-absorbing 
product in the presence of 5-HR was due to the rapid formation of an addition compound (rate 
constants = 0.08 sec-1 and 0.13 sec-1, respectively). This reaction did not occur under acidic conditions 
(pH 5.8) indicating that the reaction between 1,2-benzoquinones and 5-HR is base catalysed. 
To identify the products of the addition reaction we examined the tyrosinase reaction system 
by HPLC/MS in the presence of equimolar 5-HR and EtP at pH 8.5 and showed the generation of five 
major products (see Table 2). On the basis of their molecular weights and spectral absorption data we 
propose the formation of the products 4-9 as set out in Scheme 1. The initial addition products 
undergo redox exchange reactions and the resulting 1,2-benzoquinone products undergo ipso-
cyclisation to give 2,5-cyclohexadienones concordant with previous findings (Waiss et al., 1966; 
Crescenzi et al., 1991). 
The reaction scheme (Scheme 1) shows the proposed reaction pathway which involves two 
addition reactions between 4-ethyl-1,2-benzoquinone (3) and 5-HR (1), and five redox exchange 
reactions with the 1,2-benzoquinone (3) generating 1,2-dihydroxy-4-ethylbenzene which acts as a 
catecholic substrate  for tyrosinase. This accounts for the activation of met-tyrosinase, and hence the 
effect on the lag period (Ramsden and Riley, 2014a) and the additional oxygen utilisation. The 
calculated total oxygen stoichiometry according to the ratio of the products formed, based on the 
mean absorbances at 400 nm, is 1.35 moles of oxygen per mole of EtP which corresponds closely 
with the data obtained (Table 1). 
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We conclude that the 5-hydroxy group of 5-HR interferes with access to the active site of 
tyrosinase and further work may clarify the detailed molecular nature of this phenomenon.  The major 
action of 5-HR is as a powerful trapping agent of 1,2-benzoquinones. Its observed influence in the 
presence of phenolic substrates on the characteristics of tyrosinase-catalysed oxidation, such as the lag 
period and maximum oxidation rate, is attributable to the formation of catecholic C-addition products 
that function as secondary activating substrates for tyrosinase and which cyclise to form a range of 
unusual 2,5-cyclohexadienenones. These results explain how 5-hydroxyresorcinol acts as an activator 
of tyrosinase by enabling the generation of a catecholic substrate in a manner similar to the formation 
of dopa by redox exchange with the natural internal addition product, cyclodopa. The demonstration 
of this extraneous activation pathway suggests that the biological regulation of melanogenesis is 
sensitive to the availability of compounds able to form reductive addition compounds with 1,2-
benzoquinones. 
Supplementary data associated with the experimental details of this work can be viewed in the online 
version at http://xxx 
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Table 1. Summary of kinetic data from oxidation experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Summary of data from HPLC/MS experiments. 
 
Retention  
Time (mins)  
m/z 
(M+1) 
λmax 
(nm)
Structure 
(see Scheme 1)
Peak area at 400 nm 
(%) 
3.48 399 285 5 15 
4.35 261 418 4 31 
4.70 397 428 6 9 
4.88 397 428 7 14 
5.10 395 453 8 + 9 25 
 
 
 
 
 
 
 
 
Order of 
addition 
substrate
(nmol) 
5-HR 
(nmol)
Oxygen uptake
(nmol) 
Lag period 
(secs) 
Vmax 
(nmol min-1)
5-HR/EtP 400 400 515 24 143 
EtP/5-HR 400 400 521 5 546 
EtP/5-HR/5-HR/EtP 800 400 720 - - 
MOP 0 250 220 90 145 
MOP/5-HR 250 250 310 - - 
MOP/5-HR/MOP 250 500 615 12 456 
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Scheme 1. Reactions between 5-HR (1) and EtP (2) in the presence of tyrosinase. The proposed 
identity of the products and their molecular weights are indicated. Redox reactions with 4-ethyl-1,2-
quinone (3) are followed by ipso-cyclization. Compounds not observed by chromatography are 
indicated in square brackets. 
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